Company intelligence / Profile preview

Jin Jing

Beijing, Beijing, China

Ownership: Private
Development stage: Other

Overview

Jinjing (Beijing) Biotechnology is a high-tech enterprise specializing in the research, development, production, and sales of raw materials for molecular diagnostics and life science research. Founded in 2010 and headquartered in Beijing, the company provides a wide range of high-quality reagents, including DNA polymerases, reverse transcriptases, dNTPs, and kits for PCR, qPCR, and NGS library preparation. Jinjing Biotech serves academic institutions, diagnostic companies, and biotechnology firms globally, positioning itself as a key supplier in the molecular biology value chain. The company is known for its robust quality control systems and its ability to provide customized bulk reagents for industrial-scale applications.

Modalities: Recombinant proteinEnzymesMolecular diagnostics reagents
Industry: Chemicals & Materials

Beyond the preview

Go deeper on Jin Jing.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Jin Jing.

Explore the full profile